Drug Type Mesenchymal stem cell therapy |
Synonyms- |
Target- |
Action modulators |
Mechanism Stem cells modulators |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Pulmonary Disease, Chronic Obstructive | Phase 1 | China | 05 Nov 2025 | |
| Respiratory Distress Syndrome, Acute | Phase 1 | China | 25 Aug 2025 | |
| Menopausal symptoms | IND Approval | China | 28 Aug 2025 |





